BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21468953)

  • 1. Extraction and proteome analysis of liver tissue interstitial fluid.
    Sun W; Jiang Y; He F
    Methods Mol Biol; 2011; 728():247-57. PubMed ID: 21468953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the liver tissue interstitial fluid (TIF) proteome indicates potential for application in liver disease biomarker discovery.
    Sun W; Ma J; Wu S; Yang D; Yan Y; Liu K; Wang J; Sun L; Chen N; Wei H; Zhu Y; Xing B; Zhao X; Qian X; Jiang Y; He F
    J Proteome Res; 2010 Feb; 9(2):1020-31. PubMed ID: 20038183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of fibrosis-relevant proteins using DIGE (difference in gel electrophoresis) in different models of hepatic fibrosis.
    Henkel C; Roderfeld M; Weiskirchen R; Scheibe B; Matern S; Roeb E
    Z Gastroenterol; 2005 Jan; 43(1):23-9. PubMed ID: 15650968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid.
    Teng PN; Hood BL; Sun M; Dhir R; Conrads TP
    J Proteome Res; 2011 Mar; 10(3):1333-42. PubMed ID: 21142074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
    Wimmer H; Gundacker NC; Griss J; Haudek VJ; Stättner S; Mohr T; Zwickl H; Paulitschke V; Baron DM; Trittner W; Kubicek M; Bayer E; Slany A; Gerner C
    Electrophoresis; 2009 Jun; 30(12):2076-89. PubMed ID: 19582709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of PAXgene-fixed tissues.
    Ergin B; Meding S; Langer R; Kap M; Viertler C; Schott C; Ferch U; Riegman P; Zatloukal K; Walch A; Becker KF
    J Proteome Res; 2010 Oct; 9(10):5188-96. PubMed ID: 20812734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of the hepatic proteome in hepatitis B-infected mouse model at early stages of fibrosis.
    Spano D; Cimmino F; Capasso M; D'Angelo F; Zambrano N; Terracciano L; Iolascon A
    J Proteome Res; 2008 Jul; 7(7):2642-53. PubMed ID: 18498147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample preparation project for the subcellular proteome of mouse liver.
    Song Y; Hao Y; Sun A; Li T; Li W; Guo L; Yan Y; Geng C; Chen N; Zhong F; Wei H; Jiang Y; He F
    Proteomics; 2006 Oct; 6(19):5269-77. PubMed ID: 16941572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF).
    Gromov P; Gromova I
    Methods Mol Biol; 2016; 1459():231-47. PubMed ID: 27665563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear proteome profile of C57BL/6J mouse liver.
    Zhang Y; Fang C; Bao H; Fan H; Shen H; Yang P
    Sci China Life Sci; 2013 Jun; 56(6):513-23. PubMed ID: 23737002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis.
    Henkel C; Roderfeld M; Weiskirchen R; Berres ML; Hillebrandt S; Lammert F; Meyer HE; Stühler K; Graf J; Roeb E
    Proteomics; 2006 Dec; 6(24):6538-48. PubMed ID: 17109383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of early proteomic markers for hepatic steatosis.
    Meneses-Lorente G; Watt A; Salim K; Gaskell SJ; Muniappa N; Lawrence J; Guest PC
    Chem Res Toxicol; 2006 Aug; 19(8):986-98. PubMed ID: 16918237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suction blister fluid as potential body fluid for biomarker proteins.
    Kool J; Reubsaet L; Wesseldijk F; Maravilha RT; Pinkse MW; D'Santos CS; van Hilten JJ; Zijlstra FJ; Heck AJ
    Proteomics; 2007 Oct; 7(20):3638-50. PubMed ID: 17890648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel technique to specifically analyze the secretome of cells and tissues.
    Zwickl H; Traxler E; Staettner S; Parzefall W; Grasl-Kraupp B; Karner J; Schulte-Hermann R; Gerner C
    Electrophoresis; 2005 Jul; 26(14):2779-85. PubMed ID: 15966010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatosis-induced proteomic changes in liver mitochondria evidenced by two-dimensional differential in-gel electrophoresis.
    Douette P; Navet R; Gerkens P; de Pauw E; Leprince P; Sluse-Goffart C; Sluse FE
    J Proteome Res; 2005; 4(6):2024-31. PubMed ID: 16335947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in proximal fluid proteomics for disease biomarker discovery.
    Teng PN; Bateman NW; Hood BL; Conrads TP
    J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2D DIGE of the cerebrospinal fluid proteome in neurological diseases.
    Tumani H; Lehmensiek V; Lehnert S; Otto M; Brettschneider J
    Expert Rev Proteomics; 2010 Feb; 7(1):29-38. PubMed ID: 20121474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis.
    Teng PN; Rungruang BJ; Hood BL; Sun M; Flint MS; Bateman NW; Dhir R; Bhargava R; Richard SD; Edwards RP; Conrads TP
    J Proteome Res; 2010 Aug; 9(8):4161-9. PubMed ID: 20518575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.
    Martins-de-Souza D; Maccarrone G; Wobrock T; Zerr I; Gormanns P; Reckow S; Falkai P; Schmitt A; Turck CW
    J Psychiatr Res; 2010 Dec; 44(16):1176-89. PubMed ID: 20471030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.